Details

Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine - Canada.ca

Metadata and links for an archived snapshot.

Source
Public Health Agency of Canada
Date
Feb 18, 2026 · edition #7
Timestamp
2026-02-18T17:06:18.319Z
Language
en
Original URL
https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine/summary-february-17-2022.html
Replay URL
https://replay.healtharchive.ca/job-7/20260218170618/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine/summary-february-17-2022.html#ha_snapshot=868626
ID
868626
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview